This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wirsching, S.
Right arrow Articles by Morschhäuser, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wirsching, S.
Right arrow Articles by Morschhäuser, J.

 Previous Article  |  Next Article 

Journal of Bacteriology, January 2000, p. 400-404, Vol. 182, No. 2
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Activation of the Multiple Drug Resistance Gene MDR1 in Fluconazole-Resistant, Clinical Candida albicans Strains Is Caused by Mutations in a trans-Regulatory Factor

Stephanie Wirsching, Sonja Michel, Gerwald Köhler, and Joachim Morschhäuser*

Zentrum für Infektionsforschung, Universität Würzburg, Röntgenring 11, D-97070 Würzburg, Germany

Received 26 July 1999/Accepted 20 October 1999

Resistance of Candida albicans against the widely used antifungal agent fluconazole is often due to active drug efflux from the cells. In many fluconazole-resistant C. albicans isolates the reduced intracellular drug accumulation correlates with constitutive strong expression of the MDR1 gene, encoding a membrane transport protein of the major facilitator superfamily that is not detectably expressed in vitro in fluconazole-susceptible isolates. To elucidate the molecular changes responsible for MDR1 activation, two pairs of matched fluconazole-susceptible and resistant isolates in which drug resistance coincided with stable MDR1 activation were analyzed. Sequence analysis of the MDR1 regulatory region did not reveal any promoter mutations in the resistant isolates that might account for the altered expression of the gene. To test for a possible involvement of trans-regulatory factors, a GFP reporter gene was placed under the control of the MDR1 promoter from the fluconazole-susceptible C. albicans strain CAI4, which does not express the MDR1 gene in vitro. This MDR1P-GFP fusion was integrated into the genome of the clinical C. albicans isolates with the help of the dominant selection marker MPAR developed for the transformation of C. albicans wild-type strains. Integration was targeted to an ectopic locus such that no recombination between the heterologous and resident MDR1 promoters occurred. The transformants of the two resistant isolates exhibited a fluorescent phenotype, whereas transformants of the corresponding susceptible isolates did not express the GFP gene. These results demonstrate that the MDR1 promoter was activated by a trans-regulatory factor that was mutated in fluconazole-resistant isolates, resulting in deregulated, constitutive MDR1 expression.


* Corresponding author. Mailing address: Zentrum für Infektionsforschung, Universität Würzburg, Röntgenring 11, D-97070 Würzburg, Germany. Phone: 49-931-31 21 52. Fax: 49-931-31 25 78. E-mail: joachim.morschhaeuser{at}mail.uni-wuerzburg.de.


Journal of Bacteriology, January 2000, p. 400-404, Vol. 182, No. 2
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Znaidi, S., Weber, S., Zin Al-Abdin, O., Bomme, P., Saidane, S., Drouin, S., Lemieux, S., De Deken, X., Robert, F., Raymond, M. (2008). Genomewide Location Analysis of Candida albicans Upc2p, a Regulator of Sterol Metabolism and Azole Drug Resistance. Eukaryot Cell 7: 836-847 [Abstract] [Full Text]  
  • Manoharlal, R., Gaur, N. A., Panwar, S. L., Morschhauser, J., Prasad, R. (2008). Transcriptional Activation and Increased mRNA Stability Contribute to Overexpression of CDR1 in Azole-Resistant Candida albicans. Antimicrob. Agents Chemother. 52: 1481-1492 [Abstract] [Full Text]  
  • Cheng, S., Clancy, C. J., Nguyen, K. T., Clapp, W., Nguyen, M. H. (2007). A Candida albicans Petite Mutant Strain with Uncoupled Oxidative Phosphorylation Overexpresses MDR1 and Has Diminished Susceptibility to Fluconazole and Voriconazole. Antimicrob. Agents Chemother. 51: 1855-1858 [Abstract] [Full Text]  
  • Rognon, B., Kozovska, Z., Coste, A. T., Pardini, G., Sanglard, D. (2006). Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance. Microbiology 152: 3701-3722 [Abstract] [Full Text]  
  • Riggle, P. J., Kumamoto, C. A. (2006). Transcriptional Regulation of MDR1, Encoding a Drug Efflux Determinant, in Fluconazole-Resistant Candida albicans Strains through an Mcm1p Binding Site. Eukaryot Cell 5: 1957-1968 [Abstract] [Full Text]  
  • Hiller, D., Stahl, S., Morschhauser, J. (2006). Multiple cis-Acting Sequences Mediate Upregulation of the MDR1 Efflux Pump in a Fluconazole-Resistant Clinical Candida albicans Isolate.. Antimicrob. Agents Chemother. 50: 2300-2308 [Abstract] [Full Text]  
  • Bader, T., Schroppel, K., Bentink, S., Agabian, N., Kohler, G., Morschhauser, J. (2006). Role of Calcineurin in Stress Resistance, Morphogenesis, and Virulence of a Candida albicans Wild-Type Strain. Infect. Immun. 74: 4366-4369 [Abstract] [Full Text]  
  • Hiller, D., Sanglard, D., Morschhauser, J. (2006). Overexpression of the MDR1 Gene Is Sufficient To Confer Increased Resistance to Toxic Compounds in Candida albicans.. Antimicrob. Agents Chemother. 50: 1365-1371 [Abstract] [Full Text]  
  • Pinjon, E., Jackson, C. J., Kelly, S. L., Sanglard, D., Moran, G., Coleman, D. C., Sullivan, D. J. (2005). Reduced Azole Susceptibility in Genotype 3 Candida dubliniensis Isolates Associated with Increased CdCDR1 and CdCDR2 Expression. Antimicrob. Agents Chemother. 49: 1312-1318 [Abstract] [Full Text]  
  • Vermitsky, J.-P., Edlind, T. D. (2004). Azole Resistance in Candida glabrata: Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription Factor. Antimicrob. Agents Chemother. 48: 3773-3781 [Abstract] [Full Text]  
  • Karababa, M., Coste, A. T., Rognon, B., Bille, J., Sanglard, D. (2004). Comparison of Gene Expression Profiles of Candida albicans Azole-Resistant Clinical Isolates and Laboratory Strains Exposed to Drugs Inducing Multidrug Transporters. Antimicrob. Agents Chemother. 48: 3064-3079 [Abstract] [Full Text]  
  • De Deken, X., Raymond, M. (2004). Constitutive Activation of the PDR16 Promoter in a Candida albicans Azole-Resistant Clinical Isolate Overexpressing CDR1 and CDR2. Antimicrob. Agents Chemother. 48: 2700-2703 [Abstract] [Full Text]  
  • Rogers, P. D., Barker, K. S. (2003). Genome-Wide Expression Profile Analysis Reveals Coordinately Regulated Genes Associated with Stepwise Acquisition of Azole Resistance in Candida albicans Clinical Isolates. Antimicrob. Agents Chemother. 47: 1220-1227 [Abstract] [Full Text]  
  • Cowen, L. E., Nantel, A., Whiteway, M. S., Thomas, D. Y., Tessier, D. C., Kohn, L. M., Anderson, J. B. (2002). Population genomics of drug resistance in Candida albicans. Proc. Natl. Acad. Sci. USA 99: 9284-9289 [Abstract] [Full Text]  
  • Wirsching, S., Moran, G. P., Sullivan, D. J., Coleman, D. C., Morschhauser, J. (2001). MDR1-Mediated Drug Resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 45: 3416-3421 [Abstract] [Full Text]  
  • Staib, P., Moran, G. P., Sullivan, D. J., Coleman, D. C., Morschhäuser, J. (2001). Isogenic Strain Construction and Gene Targeting in Candida dubliniensis. J. Bacteriol. 183: 2859-2865 [Abstract] [Full Text]  
  • Uhl, M. A., Johnson, A. D. (2001). Development of Streptococcus thermophilus lacZ as a reporter gene for Candida albicans. Microbiology 147: 1189-1195 [Abstract] [Full Text]